keyword
https://read.qxmd.com/read/38477568/correction-to-effectiveness-of-opioid-switching-for-dyspnea-and-its-predictors-in-cancer-patients-a-single-center-retrospective-observational-study
#21
(no author information available yet)
No abstract text is available yet for this article.
March 13, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38472551/ocrelizumab-use-in-multiple-sclerosis-a-real-world-experience-in-a-changing-therapeutic-scenario
#22
JOURNAL ARTICLE
Lorena Lorefice, Paolo Mellino, Jessica Frau, Giancarlo Coghe, Giuseppe Fenu, Eleonora Cocco
INTRODUCTION: CD20-depleting therapies are a real milestone in the treatment of multiple sclerosis (MS). This study examined the ocrelizumab (OCR) use in patients with primary progressive (PP) and relapsing remitting (RR) MS, also evaluating the predictors of treatment response. METHODS: Patients with MS treated with OCR between 2017 and 2022 were included, and OCR use trends examined. The patients' characteristics were assessed at baseline and after 24 months of OCR to assess the NEDA-3 status...
March 12, 2024: Neurological Sciences
https://read.qxmd.com/read/38469653/short-term-personality-development-and-early-career-success-two-longitudinal-studies-during-the-post-graduation-transition
#23
JOURNAL ARTICLE
Mary-Louise Hotze, Zihan Liu, Chu Chu, Erica Baranski, Kevin A Hoff
OBJECTIVE: Investigate short-term personality development during the post-graduation transition. BACKGROUND: Prior research indicates that long-term personality development matters for employment outcomes. However, this evidence is primarily limited to multi-year longitudinal studies. This research switches the focus to personality changes during a shorter, impactful life transition. METHOD: We examined how short-term personality development during the 14-month post-graduation transition relates to early career outcomes among two diverse samples of graduates from universities (N = 816) and community colleges (N = 567)...
March 12, 2024: Journal of Personality
https://read.qxmd.com/read/38460458/psychiatric-assessment-prior-to-and-after-switch-from-levetiracetam-to-brivaracetam
#24
JOURNAL ARTICLE
Ammar Kassoum, Tassanai Intravooth, Anne-Sophie Wendling, Anke M Staack, Bernhard J Steinhoff
PURPOSE: Brivaracetam is often used as an alternative to levetiracetam in patients with epilepsy (PWE) encountering efficacy issues or adverse events with levetiracetam. This study evaluated the psychological status of PWE who were switched from levetiracetam to brivaracetam due to psychiatric tolerability concerns in comparison to those who remained on levetiracetam. METHODS: We used various psychological assessments including the Symptom Checklist SCL-90-R, the Beck Depression Inventory-II, and the adverse event profile...
February 29, 2024: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/38455412/mineralocorticoid-receptor-signaling-inhibits-bladder-cancer-progression
#25
JOURNAL ARTICLE
Yujiro Nagata, Takuro Goto, Yuki Teramoto, Takuo Matsukawa, Naohiro Fujimoto, Hiroshi Miyamoto
The biological or clinical significance of mineralocorticoid receptor (MR) in urothelial cancer remains largely unknown. The present study aimed to determine the functional role of MR in bladder cancer progression. In two of the human bladder cancer lines expressing MR, treatment with a natural MR ligand, aldosterone, significantly reduced cell proliferation and migration, which was restored by three MR antagonists clinically used, spironolactone (except colony formation of androgen receptor-positive cells cultured in the presence of androgens), eplerenone, and esaxerenone...
2024: American Journal of Cancer Research
https://read.qxmd.com/read/38452985/risks-of-infection-and-severity-of-coronavirus-disease-2019-in-kidney-transplant-recipients-a-single-center-cohort-study
#26
JOURNAL ARTICLE
Kuniaki Inoue, Shunta Hori, Mitsuru Tomizawa, Tatsuo Yoneda, Yasushi Nakai, Makito Miyake, Nobumichi Tanaka, Kiyohide Fujimoto
BACKGROUND: The severity of coronavirus disease 2019 (COVID-19) is known to be high in kidney transplant recipients; however, the risk factors for COVID-19 infection in these patients has not been studied extensively. Therefore, we explored the predictors of COVID-19 infection and severity in kidney transplant recipients in Japan. METHODS: This study included kidney transplant recipients who were regularly followed-up at our hospital from February 2021 to March 2023...
March 6, 2024: Transplant Immunology
https://read.qxmd.com/read/38433502/testosterone-therapy-reduces-insulin-resistance-in-men-with-adult-onset-testosterone-deficiency-and-metabolic-syndrome-results-from-the-moscow-study-a-randomized-controlled-trial-with-an-open-label-phase
#27
JOURNAL ARTICLE
Yuliya Tishova, Svetlana Kalinchenko, George Mskhalaya, Geoffrey Hackett, Mark Livingston, Carola König, Richard Strange, Michael Zitzmann, Amar Mann, Amro Maarouf, Sudarshan Ramachandran
AIMS: To describe changes in homeostasis model assessment of insulin resistance index (HOMA-IR) following testosterone therapy in men with hypogonadism and metabolic syndrome (MetS). MATERIALS AND METHODS: A randomized, placebo-controlled, double-blind randomized controlled trial (RCT) comprising 184 men with MetS and hypogonadism (testosterone undecanoate [TU]: 113 men, placebo: 71 men) was conducted. This was followed by an open-label phase in which all men were given TU...
March 3, 2024: Diabetes, Obesity & Metabolism
https://read.qxmd.com/read/38423758/sacroiliac-radiographic-progression-over-10-years-in-axspa-data-from-the-desir-inception-cohort
#28
JOURNAL ARTICLE
Anna Molto, Clementina López-Medina, Alexandre Sepriano, Sofia Ramiro, Manouk de Hooge, Miranda van Lunteren, Victoria Navarro-Compán, Daniel Wendling, Maxime Dougados
OBJECTIVES: To evaluate sacroiliac radiographic progression over a 10-year follow-up and determine the baseline factors associated with such progression in patients with recent-onset axial spondyloarthritis (axSpA, <3 years). METHODS: This analysis was performed in the DESIR cohort (NCT01648907). The radiographic status of the patients (radiographic axSpA (r-axSpA) vs non-radiographic axSpA (nr-axSpA)) was based on the modified New York (mNY) criteria...
February 29, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38422766/transcatheter-arterial-chemoembolisation-combined-with-lenvatinib-and-cabozantinib-in-the-treatment-of-advanced-hepatocellular-carcinoma
#29
JOURNAL ARTICLE
Hong Liu, Xue-Mei Gan, Jian-Ming Sun, Qin Yang, Dai-Zhong Zhang, Yong-Qing Zuo, Feng-Ling Liu, Bo Li, Qi-Liang Tan, Jun Zhang
OBJECTIVE: The objective of this study was to evaluate the effect and prognosis of transcatheter arterial chemoembolisation (TACE) combined with lenvatinib and cabozantinib in the treatment of advanced unresectable hepatocellular carcinoma (uHCC) and identify the predictors of prognosis related to cellular inflammation and body mass index (BMI). To the best of our knowledge, this is the first study to report the efficacy and prognosis of TACE combined with lenvatinib and cabozantinib in patients with uHCC and propose the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) as predictors of response and survival outcomes in this context...
February 28, 2024: International Immunopharmacology
https://read.qxmd.com/read/38398702/real-world-data-on-faricimab-switching-in-treatment-refractory-neovascular-age-related-macular-degeneration
#30
JOURNAL ARTICLE
Benjamin Ng, Hema Kolli, Naduviledeth Ajith Kumar, Matthew Azzopardi, Abison Logeswaran, Julius Buensalido, Bushra Mushtaq, Randhir Chavan, Yu Jeat Chong
Faricimab is a newly approved bispecific antibody for neovascular age-related macular degeneration (nAMD). Our study aims to evaluate clinical outcomes of faricimab switching in patients with treatment-refractory nAMD; determine parameters that predict these outcomes; and obtain patient subjective experience on this new injection. This is a retrospective case review with clinical and imaging data from a tertiary referral unit (Birmingham and Midland Eye Centre, UK), involving patients who were switched to faricimab between 1 January and 1 December 2023...
January 29, 2024: Life
https://read.qxmd.com/read/38398240/longitudinal-measurements-of-blood-biomarkers-in-patients-with-crohn-s-disease-or-ulcerative-colitis-treated-with-infliximab-only-the-latest-values-in-the-induction-period-predict-treatment-failure
#31
JOURNAL ARTICLE
Kim Oren Gradel, Bente Mertz Nørgård, Sonia Friedman, Jens Kjeldsen, Michael Due Larsen
Background: Few studies have incorporated longitudinal assessments or used combinations of blood biomarkers as predictors of loss of response to biologic therapy for patients with Crohn's disease (CD) or ulcerative colitis (UC). Methods: This is a population-based cohort study comprising Danish patients with CD or UC from 2008 to 2018. We used logistic regression to analyze whether levels and changes in levels of C-reactive protein (CRP), serum albumin, and hemoglobin, routinely measured during a 14-week infliximab induction period, predicted a change to another biologic medication or cessation of biologic therapy...
February 6, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38395414/branch-retinal-vein-occlusion-treated-with-anti-vegf-to-switch-or-not-to-switch
#32
JOURNAL ARTICLE
Reut Shor, Ori Segal, Dana Barequet, Eran Greenbaum, Omer Trivizki, Anat Loewenstein, Gilad Rabina
OBJECTIVE: To evaluate visual outcomes after switching from bevacizumab to ranibizumab or aflibercept in patients with macular edema (ME) secondary to branch retinal vein occlusion (BRVO). DESIGN: A retrospective, multi-center, observational study. PARTICIPANTS: Patients diagnosed with BRVO and were treated with at least 3 bevacizumab injections, before anti VEGF switch. METHODS: The follow-up period was 36 months, and the primary study outcomes assessed changes in best corrected visual acuity (BCVA) after anti VEGF switch...
February 22, 2024: Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
https://read.qxmd.com/read/38382685/validation-of-the-praetorian-score-in-a-large-s-icd-collective-usefulness-in-clinical-routine
#33
JOURNAL ARTICLE
Florian Doldi, Gerrit Frommeyer, Andreas Löher, Christian Ellermann, Julian Wolfes, Fatih Güner, Mathis Zerbst, Hauke Engelke, Dennis Korthals, Florian Reinke, Lars Eckardt, Kevin Willy
BACKGROUND: To assess the risk of unsuccessful conversion of ventricular fibrillation (VF) during defibrillation testing (DFT) with the subcutaneous implantable cardioverter defibrillator (S-ICD) the PRAETORIAN Score has been proposed. OBJECTIVE: We aimed at validating this score in a large S-ICD collective METHODS: A retrospective single-center analysis of S-ICD patients receiving intraoperative DFT was performed. DFT was performed using a stepwise protocol with 65J standard polarity, change of polarity, increase to 80J, and re-positioning if necessary...
February 19, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://read.qxmd.com/read/38372786/the-association-between-patient-and-disease-characteristics-and-the-risk-of-disease-progression-in-patients-with-prostate-cancer-on-active-surveillance
#34
JOURNAL ARTICLE
Matthijs Duijn, Theo M de Reijke, Kurdo Barwari, Marias J Hagens, Sybren P Rynja, Jos Immerzeel, Jelle O Barentsz, Auke Jager
PURPOSE: The objective of this study was to identify and assess patient and disease characteristics associated with an increased risk of disease progression in men with prostate cancer on active surveillance. METHODS: We studied patients with low-risk (ISUP GG1) or favorable intermediate-risk (ISUP GG2) PCa. All patients had at least one repeat biopsy. Disease progression was the primary outcome of this study, based on pathological upgrading. Univariate and multivariate Cox proportional hazard analyses were used to evaluate the association between covariates and disease progression...
February 19, 2024: World Journal of Urology
https://read.qxmd.com/read/38344209/impact-of-the-response-to-platinum-based-chemotherapy-on-the-second-line-immune-checkpoint-inhibitor-monotherapy-in-non-small-cell-lung-cancer-with-pd-l1-expression-%C3%A2-49-a-multicenter-retrospective-study
#35
JOURNAL ARTICLE
Akihiro Yoshimura, Takayuki Takeda, Nobutaka Kataoka, Keiko Tanimura, Mototaka Fukui, Yusuke Chihara, Shota Takei, Hayato Kawachi, Kentaro Nakanishi, Yuta Yamanaka, Nobuyo Tamiya, Ryoichi Honda, Naoko Okura, Takahiro Yamada, Kiyoaki Uryu, Junji Murai, Shinsuke Shiotsu, Hiroshige Yoshioka, Tadaaki Yamada, Takayasu Kurata, Koichi Takayama
INTRODUCTION: The efficacy of second-line immune checkpoint inhibitor (ICI) therapy is limited in non-small cell lung cancer (NSCLC) patients with ≤ 49% PD-L1 expression. Although chemoimmunotherapy is a promising strategy, platinum-based chemotherapy followed by ICI monotherapy is often used to avoid synergistic adverse events. However, predictors of the efficacy of ICI monotherapy after platinum-based chemotherapy in NSCLC with ≤ 49% PD-L1 expression remain scarce. METHODS: This multicenter retrospective study evaluated 54 advanced or recurrent NSCLC patients with ≤ 49% PD-L1 expression who were treated with second-line ICI monotherapy following disease progression on first-line platinum-based chemotherapy at nine hospitals in Japan...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38333644/adjustments-to-maintenance-therapy-and-the-reasoning-behind-them-among-copd-outpatients-in-austria-the-step-study
#36
JOURNAL ARTICLE
Florian Vafai-Tabrizi, Ulrich Schwab, Stephan Brecht, Georg-Christian Funk
BACKGROUND: Adjustments to COPD maintenance treatment are based on different guidelines. In Austria, there is a lack of real-world data on treatment adjustments of COPD outpatients and their underlying rationale. The STEP study characterised change patterns of pharmacological maintenance therapy in COPD outpatients in predefined categories of step-up, step-down and switch, the underlying reasons, and predictors in clinical routine in Austria. METHODS: STEP was a single-visit non-interventional study in Austria...
January 2024: ERJ Open Research
https://read.qxmd.com/read/38333058/mind-over-mood-exploring-the-executive-function-s-role-in-downregulation
#37
JOURNAL ARTICLE
Jose A Rodas, Jose Leon-Rojas, Brendan Rooney
Emotion regulation plays a key role in well adapted behaviour, however, factors influencing individual differences in ER are still under investigation. Across two studies we investigate the complex relationship between executive functions (EFs) and emotional downregulation through two complementary research designs. The focus lies on key components of EFs-working memory, inhibitory control, and switching-and their relationship with effective emotional regulation. Surprisingly, switching emerged as the sole significant predictor in two multiple linear regression models, challenging the conventional belief that all major EFs broadly contribute to emotional downregulation...
2024: Frontiers in Psychology
https://read.qxmd.com/read/38330226/predictors-of-complicated-disease-course-in-adults-and-children-with-crohn-s-disease-a-nationwide-study-from-the-epi-iirn
#38
JOURNAL ARTICLE
Ohad Atia, Rona Lujan, Rachel Buchuk, Shira Greenfeld, Revital Kariv, Yiska Loewenberg Weisband, Natan Ledderman, Eran Matz, Oren Ledder, Eran Zittan, Henit Yanai, Doron Shwartz, Iris Dotan, Daniel Nevo, Dan Turner
BACKGROUND: Since data on predictors of complicated Crohn's disease (CD) from unselected populations are scarce, we aimed to utilize a large nationwide cohort, the epi-IIRN, to explore predictors of disease course in children and adults with CD. METHODS: Data of patients with CD were retrieved from Israel's 4 health maintenance organizations, whose records cover 98% of the population (2005-2020). Time-to-event modeled a complicated disease course, defined as CD-related surgery, steroid-dependency, or the need for >1 class of biologics...
February 8, 2024: Inflammatory Bowel Diseases
https://read.qxmd.com/read/38323655/effectiveness-of-opioid-switching-for-dyspnea-and-its-predictors-in-cancer-patients-a-single-center-retrospective-observational-study
#39
JOURNAL ARTICLE
Yoshihiro Yamamoto, Shion Tanaka, Katsuhiko Matsuura, Seiji Yamamoto, Kimihiko Urano, Junya Okita, Eisuke Kato, Takuya Odagiri, Yuko Deguchi
BACKGROUND: Morphine is the most used opioid for dyspnea, but other opioids such as oxycodone and fentanyl are increasingly used, and opioid switching to these is sometimes undertaken. No studies have verified the effectiveness of opioid switching for relief of dyspnea. We retrospectively investigated the effectiveness of opioid switching for dyspnea and its predictors. METHODS: All patients with opioid switching for dyspnea during hospitalization at Komaki City Hospital from January 2019 to August 2022 were included...
February 6, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38318291/the-functional-role-of-cellular-senescence-during-vascular-calcification-in-chronic-kidney-disease
#40
REVIEW
Ya-Ping Fang, Yu Zhao, Jia-Yi Huang, Xin Yang, Yan Liu, Xiao-Liang Zhang
Vascular calcification (VC) has emerged as a key predictor of cardiovascular events in patients with chronic kidney disease (CKD). In recent years, an expanding body of research has put forth the concept of accelerated vascular aging among CKD patients, highlighting the significance of vascular cells senescence in the process of VC. Within the milieu of uremia, senescent vascular endothelial cells (VECs) release extracellular microvesicles (MV) that promote vascular smooth muscle cells (VSMCs) senescence, thereby triggering the subsequent osteogenic phenotypic switch and ultimately contributing to the VC process...
2024: Frontiers in Endocrinology
keyword
keyword
118155
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.